Cardio Diagnostics Holdings (CDIO) Cash from Financing Activities (2021 - 2026)

Cardio Diagnostics Holdings has reported Cash from Financing Activities for 6 years, with the latest figure at $3.6 million in Q1 2026.

• Quarterly Cash from Financing Activities rose 8.57% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (down 72.83% YoY) and the FY2025 annual result came in at $3.4 million, down 71.28% from the prior year.
• Cash from Financing Activities grew to $3.6 million in Q1 2026 per CDIO's latest filing, from $195620.0 in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $9.8 million in Q2 2022 and troughed at -$1.7 million in Q4 2022.
• A 5-year average of $2.0 million and a median of $1.1 million in 2022 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities soared 28415.99% in 2022, then slumped 127.73% in 2023.
• Over 5 years, Cash from Financing Activities stood at -$1.7 million in 2022, then jumped by 94.58% to -$93500.0 in 2023, then jumped by 7898.72% to $7.3 million in 2024, then slumped by 97.32% to $195620.0 in 2025, then jumped by 1736.37% to $3.6 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $3.6 million, $195620.0, and $39955.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.